- Full Year 2023 Ucb SA Earnings Call TranscriptFeb 28, 2024€105 (+8.09%)Earnings
- Half Year 2023 Ucb SA Earnings Call TranscriptJul 27, 2023€80.86 (+0.12%)Earnings
- Ucb SA Update on BKZ US Review and Rystiggo US Approval Call TranscriptJun 27, 2023
- Full Year 2022 Ucb SA Earnings Call TranscriptFeb 22, 2023€80.98 (+2.38%)Earnings
- Full Year 2021 UCB SA Earnings Call TranscriptFeb 24, 2022€91.9 (+4.08%)Earnings
- UCB SA to Acquire Zogenix Inc Capital Markets Call TranscriptJan 19, 2022
- Half Year 2021 UCB SA Earnings Call TranscriptJul 29, 2021€91.6 (+1.42%)Earnings
- Full Year 2020 UCB SA Earnings Call TranscriptFeb 25, 2021€86 (+5.76%)Earnings
- UCB SA at JPMorgan Healthcare Conference (Virtual) TranscriptJan 13, 2021
- Ucb SA Analysts and Investors Conference Call TranscriptNov 12, 2020
- Q2 2020 Ucb SA Earnings Call TranscriptJul 27, 2020€110.75 (+0.73%)Earnings
- Full Year 2019 Ucb SA Earnings Call TranscriptFeb 20, 2020€92.28 (+3.11%)Earnings
- Ucb SA to Acquire Ra Pharmaceuticals Inc Call TranscriptOct 10, 2019
- Q2 2019 Ucb SA Earnings Call TranscriptJul 25, 2019€71.34 (-5.03%)Earnings
- Q4 2018 Ucb SA Earnings Call TranscriptFeb 28, 2019€73.68 (-4.29%)Earnings
Full Year 2022 Ucb SA Earnings Call Transcript
Welcome to the UCB Full Year 2022 Capital Market Call. My name is Antje here, and I'm heading Investor Relations at UCB. Before I introduce you to the agenda today and hand over to the speakers, I'd like to make two remarks. This video conference is being recorded. This presentation and the following Q&A session are covered by the disclaimer and safe harbor statement as stated on Slide two of the deck. Please kindly read this carefully. With this, I'd like to introduce you to our speakers today. We will start with our CEO, Jean-Christophe Tellier, followed by our Chief Medical Officer, Iris Loew-Friedrich and she will hand over to our Head of Neurology, Charl van Zyl, who will then turn it to the Head of Immunology, Emmanuel Caeymaex. And the conclusion will be done by our -- the financial conclusion will be done by our Chief Financial Officer, Sandrine Dufour. Jean-Christophe will then finally briefly conclude this presentation before we hand over to the Q&A session. For the Q&A session, please turn up your questions into the chat or if you
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)